
Journey Through the Growth Economy
The “Journey Through the Growth Economy” Podcast highlights the builders, trends, and experts driving the most dynamic elements of our economy. This show is hosted by CG's research team and brings to life important topics across four key market sectors: Technology, Healthcare, Sustainability, and Modern Consumer. Canaccord Genuity Group Inc. is an independent investment bank powering the growth economy and driven by our clients’ success.
Visit https://www.canaccordgenuity.com/capital-markets/expertise/research-and-strategy/ for more details and send all inquiries to strategicinsights@cgf.com
This content is for informational purposes only and should not be taken as legal, business, financial or investment advice. This content is not intended to promote any product or service of Canaccord Genuity.
The opinions and views expressed in this program may not necessarily reflect the institutional views of Canaccord Genuity or its affiliates.
This program should not be copied, distributed, published, or reproduced in whole or in part without the expressed written consent of Canaccord Genuity.
Certain information contained in this program constitutes forward looking statements and there is no guarantee that these results will be achieved.
Canaccord Genuity has no obligation to provide updates or changes to the information in this program. Past performance does not guarantee future results which may vary.
Canaccord Genuity LLC is a registered broker-dealer regulated by the SEC and FINRA. Member SIPC. Canaccord Genuity Corp. Member CIRO/Canadian Investor Protection Fund. Canaccord Genuity Limited, Authorized and Regulated by the Financial Conduct Authority, Member LSE. Offices in other countries are offices of other companies in the Canaccord Genuity group of companies.
Canaccord Genuity Research Disclosures are available at the following link: https://canaccordgenuity.bluematrix.com/sellside/Disclosures.action
Journey Through the Growth Economy
Latest Episodes
Navigating Nervous Times - The Risks, Rewards, and Complexities of Neurological Indications: A Conversation with Sumant Kulkarni CG’s Biotechnology Senior Analyst

Streamlining Workflows to Differentiate Customer Experience; A Conversation with Jacob Thaysen, PhD, CEO of Illumina

Inflammation and Immunology: The Latest on Drug Development Targeting Atopic Dermatitis with Edward Nash, CG’s Biotechnology Senior Analyst

Checkup on the Software Sector: The Landscape for Apps and AI with DJ Hynes, CG‘s Applications Software Senior Analyst

S Curves and Scaling Games: A Conversation on AI with Kingsley Crane, CG Senior Analyst of Infrastructure & Security Software
